Adriamycin inhibits adipogenesis through the modulation of PPARγ and restoration of adriamycin-mediated inhibition of adipogenesis by PPARγ over-expression

Toxicology Mechanisms and Methods

Volumn 22, Issue 7, 2012, Pages 540-546

  Arunachalam, Sankarganesh ^a,b   Kim, Sun Young ^a,b   Kim, Min Sun ^a   Yi, Ho Keun ^c   Yun, Bong Sik ^d   Lee, Dae Yeol ^a,b   Hwang, Pyoung Han ^a,b  

^a Department of Pediatrics ^*  (South Korea)

^b School of Medicine   (South Korea)

^c Wonkwang Biomaterial Implant Research Institute   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

Adipogenesis; Adriamycin; Bodyweight; PPAR

Indexed keywords

DOXORUBICIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GENE TARGETING; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BODY WEIGHT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; GENE EXPRESSION REGULATION; MICE; PPAR GAMMA; TRANSFECTION; UP-REGULATION;

EID: 84865341017     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.692110     Document Type: Article

References (28)

1. Altiok S, Xu M, Spiegelman BM. 1997. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11:1987-1998. (Pubitemid 27332985)
2. Amri EZ, Dani C, Doglio A, Etienne J, Grimaldi P, Ailhaud G. 1986. Adipose cell diferentiation: evidence for a two-step process in the polyamine-dependent Ob1754 clonal line. Biochem J 238:115-122. (Pubitemid 16024985)
3. Birsoy K, Chen Z, Friedman J. 2008. Transcriptional regulation of adipogenesis by KLF4. Cell Metab 7:339-347. (Pubitemid 351455215)
4. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM. 1996. Diferential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 10:974-984. (Pubitemid 26138708)
5. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte diferentiation. Endocrinology 135:798-800. (Pubitemid 24241266)
6. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. 2005. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and-independent mechanisms. Cell Metab 1:93-106. (Pubitemid 43960592)
7. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812. (Pubitemid 3006324)
8. Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte diferentiation. Physiol Rev 78:783-809.
9. Grommes C, Landreth GE, Heneka MT. 2004. Antineoplastic efects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5:419-429. (Pubitemid 38878045)
10. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. 1998. A simplifed system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514. (Pubitemid 28145972)
11. Holst D, Luquet S, Kristiansen K, Grimaldi PA. 2003. Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdiferentiation. Exp Cell Res 288:168-176. (Pubitemid 36871006)
12. Hu E, Tontonoz P, Spiegelman BM. 1995. Transdiferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 92:9856-9860.
13. Iliskovic N, Li T, Khaper N, Palace V, Singal PK. 1998. Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem 188:161-166. (Pubitemid 28493328)
14. Keller H, Wahli W. 1993. Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? Trends Endocrinol Metab 4:291-296. (Pubitemid 24003318)
15. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556. (Pubitemid 38766330)
16. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte diferentiation. Cell 83:813-819. (Pubitemid 3006325)
17. Knauf C, Rieusset J, Foretz M, Cani PD, Uldry M, Hosokawa M, Martinez E, Bringart M, Waget A, Kersten S, Desvergne B, Gremlich S, Wahli W, Seydoux J, Delzenne NM, Torens B, Burcelin R. 2006. Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. Endocrinology 147:4067-4078. (Pubitemid 44268360)
18. Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, Kawada T. 2011. Activation of peroxisome proliferator-activated receptor-a enhances fatty acid oxidation in human adipocytes. Biochem Biophys Res Commun 407:818-822.
19. Matsusue K, Peters JM, Gonzalez FJ. 2004. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte diferentiation. FASEB J 18:1477-1479. (Pubitemid 39561620)
20. Panjrath GS, Patel V, Valdiviezo CI, Narula N, Narula J, Jain D. 2007. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model. J Am Coll Cardiol 49:2457-2464. (Pubitemid 46962267)
21. Sato K, Yonemura T, Ishii H, Toyomizu M, Kamada T, Akiba Y. 2009. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis. Comp Biochem Physiol, Part A Mol Integr Physiol 154:370-375.
22. Spiegelman BM, Green H. 1980. Control of specifc protein biosynthesis during the adipose conversion of 3T3 cells. J Biol Chem 255:8811-8818.
23. Student AK, Hsu RY, Lane MD. 1980. Induction of fatty acid synthetase synthesis in diferentiating 3T3-L1 preadipocytes. J Biol Chem 255:4745-4750. (Pubitemid 10060752)
24. Tang QQ, Lane MD. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte diferentiation. Genes Dev 13:2231-2241. (Pubitemid 29426728)
25. Teocharis S, Margeli A, Vielh P, Kouraklis G. 2004. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 30:545-554. (Pubitemid 39157854)
26. Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fbroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-1156.
27. Tontonoz P, Hu E, Spiegelman BM. 1995. Regulation of adipocyte gene expression and diferentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5:571-576.
28. Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY. 2009. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 63:343-349.